Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model

T. Ishimori (Tokyo, Japan), A. Mitani (Tokyo, Japan), S. Kohno (Tokyo, Japan), S. Nagoshi (Tokyo, Japan), M. Saito (Tokyo, Japan), H. Isago (Tokyo, Japan), H. Tamiya (Tokyo, Japan), Y. Mikami (Tokyo, Japan), T. Ishii (Tokyo, Japan), T. Jo (Tokyo, Japan), G. Tanaka (Tokyo, Japan), T. Nagase (Tokyo, Japan)

Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session: New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session type: Thematic Poster
Number: 4052
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Ishimori (Tokyo, Japan), A. Mitani (Tokyo, Japan), S. Kohno (Tokyo, Japan), S. Nagoshi (Tokyo, Japan), M. Saito (Tokyo, Japan), H. Isago (Tokyo, Japan), H. Tamiya (Tokyo, Japan), Y. Mikami (Tokyo, Japan), T. Ishii (Tokyo, Japan), T. Jo (Tokyo, Japan), G. Tanaka (Tokyo, Japan), T. Nagase (Tokyo, Japan). Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model. 4052

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


The challenge of acute exacerbation of pulmonary fibrosis
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014




Does inflammation decrease after recovery from severe exacerbation of COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018



Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


Acceleration of neutrophilic inflammation during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Inflammatory changes, recovery and recurrence at COPD exacerbation
Source: Eur Respir J 2007; 29: 527-534
Year: 2007



Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006


The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006

Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020



Clinical features of acute exacerbation in chronic birdfancier‘s lung
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Characterisation of a sub-acute mouse model of cigarette smoke extract-induced lung inflammation
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007


Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005